History | Urinary tract infection in under 16s: diagnosis and management | Guidance | NICE

Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

History

Consultation comments published

Consultation comments and responses (PDF 557 KB)

Published:

27 July 2022

Committee meetings

Committee meeting
Minutes 1 (PDF 206 KB)

Published:

08 March 2022
Minutes 2 (PDF 203 KB)

Published:

09 June 2022

Draft guidance consultation

Draft guidance consultation
Equality impact assessment (PDF 253 KB)

Published:

11 May 2022
Draft guideline (PDF 410 KB)

Published:

11 May 2022
Evidence review (PDF 12.77 MB)

Published:

11 May 2022
Committee member list (PDF 151 KB)

Published:

11 May 2022
Committee member list DOI (PDF 343 KB)

Published:

11 May 2022
Comments form (MSWord 40 KB)

Published:

11 May 2022

Declaration of interests

Register of interests (PDF 343 KB)

Published:

11 May 2022

Pre-consultation documents released

Review questions (PDF 148 KB)

Published:

01 April 2022
Search strategies (PDF 169 KB)

Published:

01 April 2022

Scope published

Final scope (PDF 147 KB)

Published:

25 January 2022

Equality and health inequalities assessment

Equality impact assessment (PDF 286 KB)

Published:

05 July 2022

Committee list updated

Committee member list (PDF 151 KB)

Published:

11 May 2022

Stakeholder list updated

Stakeholder list (PDF 154 KB)

Published:

11 May 2022

Equality and health inequalities assessment

Equality impact assessment 4 (PDF 137 KB)

Published:

11 September 2017

Addendum consultation

Addendum consultation
Addendum (PDF 4.76 MB)

Published:

21 June 2017
Short version of draft guideline (PDF 601 KB)

Published:

21 June 2017
Committee member list (PDF 365 KB)

Published:

21 June 2017
Equality impact assessment 3 (PDF 140 KB)

Published:

21 June 2017
Key research recommendations (MSWord 26 KB)

Published:

21 June 2017

Review questions document published

Review questions (PDF 239 KB)

Published:

07 November 2016

Update on 27 September 2017

Surveillance consultation
Surveillance consultation
Comments form (MSWord 30 KB)

Published:

24 July 2020
Surveillance review proposal (PDF 1.17 MB)

Published:

20 July 2020
Stakeholder list updated
Stakeholder list (PDF 115 KB)

Published:

15 July 2020
Consultation comments published
Consultation comments and responses (PDF 446 KB)

Published:

27 September 2017
Equality and health inequalities assessment
Equality impact assessment 4 (PDF 137 KB)

Published:

27 September 2017
Equality and health inequalities assessment
Equality impact assessment 4 (PDF 137 KB)

Published:

11 September 2017
Addendum consultation
Addendum consultation
Key research recommendations (MSWord 26 KB)

Published:

21 June 2017
Short version of draft guideline (PDF 601 KB)

Published:

21 June 2017
Addendum (PDF 4.76 MB)

Published:

21 June 2017
Equality impact assessment 3 (PDF 140 KB)

Published:

21 June 2017
Committee member list (PDF 365 KB)

Published:

21 June 2017
Review questions document published
Review questions (PDF 239 KB)

Published:

19 April 2017

Original development on 22 August 2007

Consultation comments published
Consultation comments and responses (PDF 95 KB)

Published:

26 May 2011
Surveillance consultation
Surveillance consultation
Surveillance review proposal (PDF 107 KB)

Published:

18 November 2010
Consultation comments published
Consultation comments and responses (PDF 328 KB)

Published:

12 September 2007
Stakeholder list updated
Stakeholder list (PDF 38 KB)

Published:

12 April 2007
Draft guidance consultation
Draft guidance consultation
Comments form (MSWord 44 KB)

Published:

13 October 2006
Supporting documentation : algorithm to NICE guideline (PDF 45 KB)

Published:

13 October 2006
Draft guideline (PDF 146 KB)

Published:

13 October 2006
Supporting documentation : algorithm to full guideline (PDF 45 KB)

Published:

13 October 2006
Full guideline updated (including evidence tables and references) (PDF 2.6 MB)

Published:

13 October 2006
Consultation comments published
Consultation comments and responses Scope (PDF 250 KB)

Published:

15 August 2005
Committee list updated
Committee member list (PDF 13 KB)

Published:

09 May 2005
Scope published
Final scope (PDF 100 KB)

Published:

09 May 2005
Draft scope consultation
Comments form (MSWord 44 KB)

Published:

09 February 2005
Draft scope (PDF 98 KB)

Published:

09 February 2005